Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

ABBV

AbbVie (ABBV)

AbbVie Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:ABBV

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next >>

Date	Time	Source	Headline	Symbol	Company
03/08/2023	8:00AM	PR Newswire (US)	AbbVie to Present at the Barclays Global Healthcare Conference	NYSE:ABBV	AbbVie Inc
03/06/2023	5:02PM	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NYSE:ABBV	AbbVie Inc
03/02/2023	5:08PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
03/02/2023	5:08PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
03/02/2023	5:05PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
03/02/2023	5:04PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
03/02/2023	5:03PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
03/02/2023	4:31PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
03/02/2023	4:31PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
02/28/2023	8:51AM	PR Newswire (US)	AbbVie to Present at the Cowen 43rd Annual Health Care Conference	NYSE:ABBV	AbbVie Inc
02/27/2023	6:00AM	PR Newswire (US)	AbbVie Highlights Robust Gastroenterology Portfolio with New Analyses and Data in Inflammatory Bowel Diseases at the 18th Congress of European Crohn's and Colitis Organisation (ECCO)	NYSE:ABBV	AbbVie Inc
02/27/2023	2:00AM	PR Newswire (US)	AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults with Moderate to Severe Crohn's Disease	NYSE:ABBV	AbbVie Inc
02/23/2023	5:01AM	PR Newswire (US)	AbbVie and Capsida Biotherapeutics Expand Strategic Collaboration to Develop Targeted Genetic Medicines for Eye Diseases with High Unmet Need	NYSE:ABBV	AbbVie Inc
02/23/2023	4:59AM	PR Newswire (US)	AbbVie and Capsida Biotherapeutics Expand Strategic Collaboration to Develop Targeted Genetic Medicines for Eye Diseases with High Unmet Need	NYSE:ABBV	AbbVie Inc
02/22/2023	5:03PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
02/21/2023	6:17PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
02/21/2023	6:13PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
02/21/2023	6:12PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
02/21/2023	6:11PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
02/21/2023	6:10PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
02/21/2023	6:09PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
02/21/2023	6:07PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
02/21/2023	6:06PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
02/21/2023	6:02PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
02/21/2023	6:01PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
02/16/2023	12:41PM	PR Newswire (US)	AbbVie Declares Quarterly Dividend	NYSE:ABBV	AbbVie Inc
02/16/2023	6:01AM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NYSE:ABBV	AbbVie Inc
02/09/2023	10:56AM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NYSE:ABBV	AbbVie Inc
02/09/2023	10:55AM	Dow Jones News	AbbVie on Pace for Largest Percent Increase Since October 2021 -- Data Talk	NYSE:ABBV	AbbVie Inc
02/09/2023	7:56AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ABBV	AbbVie Inc